Obsidian Therapeutics, Inc. ·

OBX 8-K 2026-08-14

Obsidian Therapeutics, Inc. (OBX) 8-K dated 2026-08-14 — accession 0001193125-26-352388. This URL is the filing, not the OBX hub.

Obsidian Therapeutics, Inc. (OBX) common stock.

Obsidian Therapeutics, Inc. filed a 8-K on 2026-08-14. Accession 0001193125-26-352388.

Cached items: 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OBX revenue for 2026-06-30 was $0. Net income was -$25.9M.

Not investment advice. The OBX SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR